Literature DB >> 6965382

Ability of NZW but not NZB antigen-presenting cells to support T cell proliferative response to DNA methylated albumin.

R Papoian, N Talal.   

Abstract

The genetic contribution of the parental NZB and NZW mouse to the antigen-induced, macrophage-dependent, lymph node T cell proliferative response to d-DNA-mBSA was studied in F1 hybrid NZB/NZW (B/W) mice. Mice were immunized subcutaneously in the tail with denatured DNA-methylated BSA. Primed T cells from these mice were obtained after passage of immune periaortic and inguinal lymph node cells through nylon wool. The primed T cells were exposed in vitro to d-DNA-mBSA presented on spleen cells from BALB/c, DBA/2, NZB, NZW, or B/W mice. Immune B/W T cells gave a substantial proliferative response only in the presence of antigen-presenting cells from B/W or NZW mice. These results suggest that the response of B/W mice to DNA occurs primarily through the NZW H-2 haplotype of their own antigen-presenting cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6965382

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Genetic regulation of the class conversion of dsDNA-specific antibodies in (NZB X NZW)F1 hybrid.

Authors:  A Kohno; H Yoshida; K Sekita; N Maruyama; S Ozaki; S Hirose; T Shirai
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

2.  Defective LN cell proliferative response to Sm antigen in mice bearing the lpr gene.

Authors:  H Dang; M Fischbach; V Fey; N Talal
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

3.  Ability of isoprinosine to restore interleukin-2 production and T cell proliferation in autoimmune mice.

Authors:  M Fischbach; N Talal
Journal:  Clin Exp Immunol       Date:  1985-08       Impact factor: 4.330

4.  Enhancing effect of H-2-linked NZW gene(s) on the autoimmune traits of (NZB X NZW)F1 mice.

Authors:  S Hirose; R Nagasawa; I Sekikawa; M Hamaoki; Y Ishida; H Sato; T Shirai
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.